PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

Completed · Phase 2

Conditions studied: Adult Hepatocellular Carcinoma, Localized Resectable Adult Liver Carcinoma

In brief

This clinical trial studies positron emission tomography (PET)/computed tomography (CT) in diagnosing patients with liver cancer undergoing surgical resection. Diagnostic procedures, such as fluorine-18 fluoromethylcholine PET/CT, may help find and diagnose liver cancer.

Key facts

Study ID

NCT01395030

Run by

Queen's Medical Center

People needed

64

Starts

2011-08-15

Expected to finish

2018-05-31

Last updated by the study team

2018-09-26

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Liver tumor diagnosed histologically as HCC or suspected of being HCC in association with serum alpha-fetoprotein level > 200 or tumor mass with characteristics of malignancy on diagnostic imaging
• Under the care of a surgical attending
• Deemed a surgical candidate and has agreed to surgery to remove a portion of the liver containing tumor
• Child-Pugh A/B

You may not qualify if…

• Weight > 350 lbs
• Pregnant or lactating female, a serum pregnancy test will be performed within 2 weeks or less before the date of the FCH PET/CT scan in all women capable of becoming pregnant
• Serious underlying medical condition that would impair patient's ability to tolerate the imaging procedure
• Concurrent treatment with chemotherapy, molecule-selective, biological, or radiotherapeutic agent

Where it is running

• University of Hawaii Cancer Center — Honolulu, Hawaii, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.